Generic Injectable Market 2021, Growth Rate, Statics, Business Opportunity and Forecast By 2026

SHERIDAN, WYOMING, UNITED STATES, September 22, 2021 /EINPresswire.com/ — The latest report by IMARC Group, titled “Generic Injectables Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026,” finds that the global generic injectables market size is witnessing moderate growth. Generic injectables consist of the same active ingredients as that of their branded counterparts. They also offer similar active therapeutic effects, strength, quality, performance, intended usage, and dosage. Injectables help in the easy transportation of drugs directly into the body in liquid form, which reduces the frequency of dosage administration without affecting the effectiveness of the treatment. They also do not require extensive investments, resulting in limited price erosion and significantly high-profit margins for manufacturers.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request for a free sample copy of this report: https://www.imarcgroup.com/generic-injectables-market/requestsample

Global Generic Injectables Market Trends:

The global generic injectables market is primarily driven by their growing preference over oral counterparts as they are preferred by patients who are unable to take medicines by mouth and have poor intestinal absorption. Apart from this, governments across various countries are supporting the manufacturing of generic injectables to reduce the overall cost for healthcare providers and patients. Besides this, the increasing prevalence of chronic diseases like diabetes, cardiovascular disorders, and Alzheimer’s, especially among the geriatric population, and the rising shortage of drugs are significantly contributing to the market growth. Furthermore, several key players are engaging in acquisitions and focusing on research and development (R&D) activities to develop complex and differentiated products. For instance, Agila Injectables have been acquired by Mylan Inc. from Strides Arcolab Limited to expand their existing product portfolio. On account of these factors, the market value is expected to reach US$ 445.3 Billion by 2026, exhibiting a CAGR of 7.11% during the forecast period (2021-2026).

Buy full report with table of contents: https://www.imarcgroup.com/generic-injectables-market

Key Market Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

• Hospira, Inc. (Pfizer Inc.)
• Fresenius Kabi AG
• Hikma Pharmaceuticals PLC
• Sandoz (Novartis)
• Sagent M&C, LLC
• Sanofi S.A.
• Baxter International, Inc.

Breakup by Therapeutic Area:
• Oncology
• Anaesthesia
• Anti-infectives
• Parenteral Nutrition
• Cardiovascular

Breakup by Container:
• Vials
• Ampoules
• Premix
• Prefilled Syringes

Breakup by Distribution Channel:
• Hospitals
• Retail Pharmacy

Breakup by Region:
• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:
• Market Performance (2015-2020)
• Market Outlook (2021-2026)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Other Reports by IMARC Group:

Refrigerated Transport Market: https://www.imarcgroup.com/refrigerated-transport-market

Chemical Logistics Market: https://www.imarcgroup.com/chemical-logistics-market

Power Transistors Market: https://www.imarcgroup.com/power-transistors-market

Baby Cribs and Cots Market: https://www.imarcgroup.com/baby-cribs-cots-market

Cervical Cancer Diagnostics Market: https://www.imarcgroup.com/cervical-cancer-diagnostics-market

Amino Acids Market: https://www.imarcgroup.com/amino-acid-technical-material-market-report

Interior Architectural Coatings Market: https://www.imarcgroup.com/interior-architectural-coatings-market

Fixed Satellite Services Market: https://www.imarcgroup.com/fixed-satellite-services-market

Television Advertising Market: https://www.imarcgroup.com/television-advertising-market

Electric Lawn Mower Market: https://www.imarcgroup.com/electric-lawn-mower-market

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here


Source: EIN Presswire